GeneDx Holdings (WGS) Return on Capital Employed (2020 - 2026)
GeneDx Holdings (WGS) posted quarterly Return on Capital Employed of 15.44% for Q1 2026, down 1156.0% YoY from 1.46% in Q1 2025, and down 372.24% sequentially from 3.27% in Q4 2025.
GeneDx Holdings (WGS) Return on Capital Employed (2020 - 2026) Analysis & Trends
GeneDx Holdings has disclosed Return on Capital Employed across 6 years of filings, most recently posting 15.44% for Q1 2026.
- In Q1 2026, Return on Capital Employed fell 1156.0% year-over-year to 15.44%; the TTM figure through Mar 2026 stood at 15.44% (down 1156.0% YoY), while the FY2025 annual figure was 3.61%, up 277.0% from the prior year.
- Return on Capital Employed fell to 15.44% in Q1 2026, from 3.27% in the prior quarter.
- Over the last five years, Return on Capital Employed for WGS reached as high as 2.55% in Q3 2025 and fell as low as 160.04% in Q1 2023.
- The 5-year median for Return on Capital Employed is 37.62% (2024), against an average of 54.64%.
- Annual changes were most pronounced in 2022 — Return on Capital Employed soared 25153 bps — and 2023, when it tumbled 8220 bps.
- A 5-year view of Return on Capital Employed shows it stood at 129.47% in 2022, then surged by 61 bps to 50.28% in 2023, then jumped by 87 bps to 6.46% in 2024, then jumped by 49 bps to 3.27% in 2025, then sank by 372 bps to 15.44% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 15.44%, 3.27%, and 2.55% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 4.82% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 8.12% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 6.26% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 67.98% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -3.63% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 14.57% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 10.24% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 16.90% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 45.73% |
| 10 | GeneDx Holdings | 2.10 Bn | 1.93 Bn | 68.21 Mn | -15.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.44% |
| Dec 31, 2025 | -3.27% |
| Sep 30, 2025 | 2.55% |
| Jun 30, 2025 | 1.42% |
| Mar 31, 2025 | -3.88% |
| Dec 31, 2024 | -6.46% |
| Sep 30, 2024 | -17.93% |
| Jun 30, 2024 | -28.70% |
| Mar 31, 2024 | -37.62% |
| Dec 31, 2023 | -50.28% |
| Sep 30, 2023 | -126.78% |
| Jun 30, 2023 | -123.73% |
| Mar 31, 2023 | -160.04% |
| Dec 31, 2022 | -129.47% |
| Sep 30, 2022 | -63.79% |
| Jun 30, 2022 | -87.55% |
| Mar 31, 2022 | -77.84% |
| Dec 31, 2021 | -93.45% |
| Sep 30, 2021 | -143.29% |
| Jun 30, 2021 | -339.07% |